Our opinion on the current state of REINET(RNI)Reinet (RNI) is an investment holding company whose primary asset was a 2.12% holding in British American Tobacco (BAT), valued at approximately $1.8 billion, which accounted for 31% of its net asset value (NAV). This figure has decreased significantly from 85% ten years ago, largely due to a decline in BAT's share price. This decline reflects increasing legal challenges for the tobacco industry, particularly in the US, where the FDA is considering changes to menthol cigarette regulations.
Despite this, Reinet showed little urgency to divest from BAT as it continued to receive strong dividends from growth in developing markets, even as cigarette sales declined in developed countries. As BAT's value decreased, other assets in Reinet's portfolio became more prominent. The largest of these is its 46% stake in Pension Insurance Corporation (Penscorp), which now represents 36.8% of its portfolio. Additionally, the company owns a variety of private equity investments accounting for approximately 15% of its portfolio. Since March 2009, Reinet has achieved a compound growth rate of 8.8% per annum.
In its results for the six months to 30th September 2024, Reinet reported a NAV of 3625 euro cents per share, up from 3089 euro cents a year earlier. The company emphasized that it has no direct exposure to Russia, Ukraine, or the Middle East through its underlying investments or banking relationships and has not faced significant direct impacts from interest rate fluctuations or inflation.
The share is considered a rand-hedge investment. While it fell from a high of R343 in February 2020 to lows in January 2021, we recommended waiting for a break above its long-term downward trendline. That break occurred on 16th September 2019 at R270 per share, and the share is now trading at R480.31. It faced a setback after BAT announced a GBP25 million write-down of its US operations, which caused a 10% fall in BAT's share price.
On 13th January 2025, Reinet announced the sale of its entire BAT holding, which accounted for 24% of its total portfolio, for GBP 1.221 billion. This marked a significant shift in the company's asset composition. Subsequently, on 22nd January 2025, Reinet announced that its NAV as of 31st December 2024 was 40.46 euros based on 171.3 million shares in issue. However, in a quarterly report on 24th January 2025, the company adjusted its NAV figure to 38.12 euros as of the same date.
This share benefits from any weakness in the rand, and investors should carefully consider the currency's future prospects before making decisions. With the sale of its BAT holding, Reinet’s portfolio diversification and growth strategy will be a key area for investors to monitor going forward.
REINI trade ideas
Our opinion on the current state of REINET(RNI)Reinet (RNI) is an investment holding company whose main asset is a holding of roughly 2,12% of British American Tobacco (BAT) worth about $1,8bn, which now accounts for 31% of its net asset value (NAV)—down from 85% ten years ago. This decline from a year ago is because the price of BAT shares has fallen. Most of this reflects the more difficult legal environment for tobacco, especially in the US, where the Food and Drug Administration is considering changing the laws on menthol cigarettes.
In our view, Reinet shows no great urgency to divest itself of the BAT stake, which continues to contribute good dividends from growth in third-world countries, while cigarette sales in first-world countries fall. As the price of BAT has fallen, the other assets in the Reinet portfolio have become more significant. The largest of these is its 46% stake in Pension Insurance Corporation (Penscorp), which now represents 36,8% of its portfolio.
Aside from Penscorp, the company also owns a spread of private equity investments, which account for around 15% of the portfolio. The company has a compound growth rate of 8,8% per annum since March 2009. In its results for the six months to 30th September 2024, the company reported a net asset value (NAV) of 3625 euro cents per share—up from 3089c a year earlier. The company said, "Reinet has no direct exposure to Russia, Ukraine, or the Middle East through its underlying investments or banking relationships and has not experienced any significant direct impacts in respect of interest rate fluctuations or inflation."
The share is obviously a rand-hedge and, although it fell from its high of R343 in February 2020 to lows in January 2021, we advised waiting for a break up through its long-term downward trendline. That break came on 16th September 2019 at R270 per share. It is now trading for R480.31. It obviously took a hit as a result of the BATS announcement that it was writing the value of its US operation down by GBP25m (R595bn), resulting in a 10% fall in the BATS share price.
This share benefits from any weakness in the rand, and investors should consider the rand's future prospects before buying. On 13th January 2025, Reinet announced that it had sold its entire holding of BATS, which was 24% of the value of its total portfolio, for GBP 1,221bn.
Our opinion on the current state of REINET(RNI)Reinet (RNI) is an investment holding company with its main asset being a 2.12% stake in British American Tobacco (BAT), valued at approximately $1.8 billion, which constitutes about 31% of its net asset value (NAV). This is a significant reduction from 85% a decade ago, primarily due to the decline in BAT's share price as the tobacco industry faces increasing regulatory challenges, particularly in the US.
The US Food and Drug Administration's potential regulatory changes on menthol cigarettes and the global trend of declining cigarette sales in developed markets have contributed to BAT's declining valuation. However, BAT continues to deliver solid dividends, driven by growth in emerging markets where tobacco demand remains relatively strong.
Diversification and Portfolio:
1. Pension Insurance Corporation (Penscorp): Reinet holds a 46% stake in Penscorp, now representing 36.8% of its portfolio. This has grown in prominence as BAT's contribution has declined.
2. Private Equity Investments: Private equity holdings now account for around 15% of Reinet's portfolio, contributing to its diversification strategy.
3. Compound Growth: Since March 2009, Reinet's portfolio has achieved a compound annual growth rate of 8.8%.
Financial Performance:
- For the six months ending 30th September 2024, Reinet reported an NAV of 3625 euro cents per share, up from 3089 euro cents a year earlier.
- The company stated that it has no direct exposure to geopolitical risks such as Russia, Ukraine, or the Middle East and has been minimally affected by interest rate fluctuations or inflation.
Technical Performance:
- The share price fell sharply from its high of R343 in February 2020, hitting lows in January 2021.
- A clear upward break through its long-term downward trendline occurred on 16th September 2019 at R270 per share.
- The share has since recovered strongly and is now trading at R480.31.
Outlook:
- The BAT announcement of a GBP25 million write-down on its US operations recently impacted Reinet, reflecting BAT's ongoing challenges. However, Reinet's diversification into other asset classes, particularly Penscorp, has helped offset BAT's declining value.
- As a rand-hedge investment, Reinet is sensitive to fluctuations in the rand. Prospective investors should assess the rand's future trajectory before investing.
Reinet remains a diversified holding with a steady track record and benefits from its balanced exposure to high-dividend assets like BAT and growth-focused assets like Penscorp and private equity investments. However, its reliance on BAT, despite diversification, makes it partially exposed to the challenges in the tobacco industry.
Our opinion on the current state of REINET(RNI)Reinet (RNI) is an investment holding company with its primary asset being a 2.12% stake in British American Tobacco (BAT), valued at around $1.8 billion, which now represents 31% of its net asset value (NAV). This is a significant decrease from the 85% share of NAV BAT held ten years ago. The reduction in BAT's contribution is largely due to the decline in its share price, driven by a more challenging legal environment for tobacco, particularly in the US, where the Food and Drug Administration is considering regulatory changes to menthol cigarettes.
Despite these challenges, Reinet has not shown urgency in divesting its BAT stake, as BAT continues to provide substantial dividends, especially from its growth in emerging markets, while cigarette sales in developed markets decline. The lower valuation of BAT has also increased the significance of Reinet’s other assets, particularly its 46% stake in Pension Insurance Corporation (Penscorp), which now represents 36.8% of its portfolio. In addition to Penscorp, Reinet holds a range of private equity investments that account for about 15% of its portfolio.
Since March 2009, Reinet has achieved a compound annual growth rate of 8.8%. The company reported an NAV of 3669 euro cents at 30th June 2024, and by 30th September 2024, its NAV had increased to 3848 euro cents.
Reinet is considered a rand-hedge stock, meaning it benefits from any weakness in the South African rand. After falling from its high of R343 in February 2020, the share reached lows in January 2021. Investors were advised to wait for a break through the long-term downward trendline, which occurred on 16th September 2019 at R270 per share. The share is now trading at R451.42.
The share was negatively affected by a 10% drop in BAT’s share price after BAT announced it was writing down the value of its US operations by GBP25 million (R595 billion). Investors should consider the future prospects of the rand when evaluating Reinet, as further weakness in the currency could benefit the stock's performance.
Our opinion on the current state of REINET(RNI)Reinet (RNI) is an investment holding company primarily noted for its significant stake in British American Tobacco (BAT). This stake, which represents roughly 2.12% of BAT, is worth about $1.8 billion and accounts for 31% of Reinet's net asset value (NAV), down from 85% ten years ago. This decline in proportion is mainly due to a drop in BAT's share price, reflecting a more challenging legal environment for tobacco, especially in the US where the Food and Drug Administration is considering new regulations on menthol cigarettes.
Despite the reduced value of the BAT holding, Reinet has shown no urgency to divest this asset. BAT continues to provide substantial dividends, driven by growth in third-world countries despite declining cigarette sales in first-world countries. As BAT's share price has fallen, the significance of other assets in Reinet's portfolio has grown. The largest of these is its 46% stake in Pension Insurance Corporation (Penscorp), now representing 36.8% of the portfolio. Additionally, Reinet has a diverse range of private equity investments accounting for around 15% of its portfolio.
In its results for the year ending 31st March 2024, Reinet reported an 8.1% increase in NAV, reaching 3402 euro cents per share, with a compound annual growth rate of 8.8% since March 2009. By 30th June 2024, the NAV had further increased to 3669 euro cents per share. As a rand-hedge stock, Reinet's value benefits from any weakening of the rand.
Technically, the share fell from a high of R343 in February 2020 to lows in January 2021. The recommendation was to wait for a break up through its long-term downward trendline, which occurred on 16th September 2019 at R270 per share. It is now trading at R451.42. The share experienced a significant decline following an announcement by BAT about writing down the value of its US operations by GBP25 million (R595 billion), which led to a 10% drop in BAT's share price.
Investors considering Reinet should factor in the potential movements of the rand, given its influence on the share's performance. Despite the volatility linked to BAT's challenges, Reinet's diversified portfolio and steady NAV growth make it a resilient investment option.
Our opinion on the current state of REINET(RNI)Reinet (RNI) is an investment holding company whose main asset is a holding of roughly 2.12% of British American Tobacco (BAT) worth about $1.8bn, which now accounts for 31% of its net asset value (NAV) - down from 85% ten years ago. This decline from a year ago is because the price of BAT shares has fallen. Most of this reflects the more difficult legal environment for tobacco, especially in the US where the Food and Drug Administration is considering changing the laws on menthol cigarettes.
In our view, Reinet shows no great urgency to divest itself of the BAT stake - which continues to contribute good dividends from growth in third world countries, while cigarette sales in first world countries fall. As the price of BAT has fallen, the other assets in the Reinet portfolio have become more significant. The largest of these is its 46% stake in Pension Insurance Corporation (Penscorp), which now represents 36.8% of its portfolio. Aside from Penscorp, the company also owns a spread of private equity investments, accounting for around 15% of the portfolio.
In its results for the year to 31st March 2024, the company reported its net asset value up 8.1% at 3402 euro cents per share. The company has a compound growth rate of 8.8% per annum since March 2009. The share is obviously a rand-hedge and, although it fell from its high of R343 in February 2020 to lows in January 2021, it has since recovered.
We advised waiting for a break up through its long-term downward trendline. That break came on 16th September 2019 at R270 per share. It is now trading for R490.50. It obviously took a hit as a result of the BATS announcement that it was writing the value of its US operation down by GBP25m (R595bn), resulting in a 10% fall in the BATS share price. This share benefits from any weakness in the rand, and investors should consider the rand's future prospects before buying.
Given the diversification of its portfolio and its rand-hedge properties, Reinet remains an attractive investment option for those looking to hedge against local currency risk. However, the dependence on BAT and the volatile legal environment for tobacco should be taken into account. Investors should weigh these factors alongside the broader economic context and their own risk tolerance before making a decision.
Our opinion on the current state of REINET(RNI)Reinet Investments S.C.A. (RNI) is an investment holding company, with its primary asset being a significant stake in British American Tobacco (BAT), constituting roughly 2.12% of BAT's shares. This stake is valued at approximately $1.8 billion and represents about 31% of Reinet's net asset value (NAV), a substantial decrease from 85% a decade ago. The reduction in the proportion of BAT's contribution to Reinet's NAV is primarily due to the declining share price of BAT, influenced by challenging regulatory environments for tobacco products, particularly in the United States where potential legislative changes regarding menthol cigarettes are being considered.
Despite the falling price of BAT shares, Reinet has not shown a strong inclination to divest from BAT, which continues to deliver robust dividend returns, especially from markets in developing countries, even as cigarette sales in developed nations decline. As BAT's share price has dropped, other assets within Reinet's portfolio have grown in relative importance. Notably, Reinet holds a 46% stake in Pension Insurance Corporation (Penscorp), which now accounts for 36.8% of its portfolio.
Besides Penscorp, Reinet also manages a diverse array of private equity investments, making up around 15% of its portfolio. As of the fiscal year ending on 30th September 2023, Reinet reported a NAV of 30.89 euros per share, a slight decrease from 31.46 euros in the previous year, reflecting a 1.8% decline. This decrease was attributed to reductions in the fair value of several investments, including its holdings in BAT, Pension Corporation, and the Prescient China funds.
On 22nd January 2024, Reinet updated its NAV to 33.47 euros per share, reflecting a total value of 5.734 billion euros with 171.3 million shares outstanding. By 31st March 2024, the company's NAV further adjusted to 3611 euro cents per share.
The company's stock performance has been somewhat volatile, especially in response to global events and announcements, such as the BAT's decision to write down the value of its U.S. operations by GBP 25 million (approximately R595 billion), which led to a 10% drop in BAT's share price. This impact on BAT also indirectly affected Reinet's share valuation.
Reinet's shares serve as a hedge against the rand's weakness, benefitting from any depreciation in the South African currency. Investors considering Reinet should thus weigh the potential risks associated with its significant exposure to BAT and the broader tobacco industry's regulatory challenges, alongside evaluating the stability and growth potential of its other investments like Penscorp and its array of private equity assets. As always, the future prospects of the rand and its impact on Reinet's performance should be carefully considered.
Our opinion on the current state of RNIReinet (RNI) is an investment holding company whose main asset is a holding of roughly 2,12% of British American Tobacco (BAT) worth about $1,8bn which now accounts for 31% of its net asset value (NAV) - down from 85% ten years ago. This decline from a year ago is because the price of BAT shares has fallen. Most of this reflects the more difficult legal environment for tobacco, especially in the US where the Food and Drug Administration is considering changing the laws on menthol cigarettes. In our view, Reinet shows no great urgency to divest itself of the BAT stake - which continues to contribute good dividends from growth in third world countries, while cigarette sales in first world countries fall. As the price of BAT has fallen, so the other assets in the Reinet portfolio have become more significant. The largest of these is its 46% stake in Pension Insurance Corporation (Penscorp) which now represents 36,8% of its portfolio. Aside from Penscorp, the company also owns a spread of private equity investments which account for around 15% of the portfolio. In its results for the year to 30th September 2023 the company reported a net asset value (NAV) of 30,89 euros per share compared with 31,46 euros in the previous period which is a decrease of 1,8%. The company said, "The decrease in the NAV of € 104 million during the period reflects decreases in the estimated fair value of certain investments including British American Tobacco p.l.c. (‘BAT’), Pension Insurance Corporation Group Limited (‘Pension Corporation’) and Prescient China funds." On 22nd January 2024 the company reported its NAV as 33,47 euros per share or 5,734bn euros in total with 171,3m shares in issue. The share is obviously a rand-hedge and, although it fell from its high of R343 in February 2020 to lows in January 2021. We advised waiting for a break up through its long-term downward trendline. That break came on 16th September 2019 at R270 per share. It is now trading for R470.60. It obviously took a hit as a result of the BATS announcement that it was writing the value of its US operation down by GBP25m (R595bn) resulting in a 10% fall in the BATS share price. This share benefits from any weakness in the rand and investors should consider the rand's future prospects before buying.
Our opinion on the current state of RNIReinet (RNI) is an investment holding company whose main asset is a holding of roughly 2,12% of British American Tobacco (BAT) worth about $1,8bn which now accounts for 31% of its net asset value (NAV) - down from 85% ten years ago. This decline from a year ago is because the price of BAT shares has fallen. Most of this reflects the more difficult legal environment for tobacco, especially in the US where the Food and Drug Administration is considering changing the laws on menthol cigarettes. In our view, Reinet shows no great urgency to divest itself of the BAT stake - which continues to contribute good dividends from growth in third world countries, while cigarette sales in first world countries fall. As the price of BAT has fallen, so the other assets in the Reinet portfolio have become more significant. The largest of these is its 46% stake in Pension Insurance Corporation (Penscorp) which now represents 36,8% of its portfolio. Aside from Penscorp, the company also owns a spread of private equity investments which account for around 15% of the portfolio. In its results for the year to 30th September 2023 the company reported a net asset value (NAV) of 30,89 euros per share compared with 31,46 euros in the previous period which is a decrease of 1,8%. The company said, "The decrease in the NAV of € 104 million during the period reflects decreases in the estimated fair value of certain investments including British American Tobacco p.l.c. (‘BAT’), Pension Insurance Corporation Group Limited (‘Pension Corporation’) and Prescient China funds". The share is obviously a rand-hedge and, although it fell from its high of R343 in February 2020 to lows in January 2021. We advised waiting for a break up through its long-term downward trendline. That break came on 16th September 2019 at R270 per share. It is now trading for R436.51. It obviously took a hit as a result of the BATS announcement that it was wriitng the value of its US operation down by GBP25m (R595bn) resulting in a 10% fall in the BATS share price. This share benefits from any weakness in the rand and investors should consider the rand's future prospects before buying.
Our opinion on the current state of RNIReinet (RNI) is an investment holding company whose main asset is a holding of roughly 2,12% of British American Tobacco (BAT) worth about $1,8bn which now accounts for 31% of its net asset value (NAV) - down from 85% ten years ago. This decline from a year ago is because the price of BAT shares has fallen. Most of this reflects the more difficult legal environment for tobacco, especially in the US where the Food and Drug Administration is considering changing the laws on menthol cigarettes. In our view, Reinet shows no great urgency to divest itself of the BAT stake - which continues to contribute good dividends from growth in third world countries, while cigarette sales in first world countries fall. As the price of BAT has fallen, so the other assets in the Reinet portfolio have become more significant. The largest of these is its 46% stake in Pension Insurance Corporation (Penscorp) which now represents 36,8% of its portfolio. Aside from Penscorp, the company also owns a spread of private equity investments which account for around 15% of the portfolio. In its results for the year to 30th September 2023 the company reported a net asset value (NAV) of 30,89 euros per share compared with 31,46 euros in the previous period which is a decrease of 1,8%. The company said, "The decrease in the NAV of € 104 million during the period reflects decreases in the estimated fair value of certain investments including British American Tobacco p.l.c. (‘BAT’), Pension Insurance Corporation Group Limited (‘Pension Corporation’) and Prescient China funds". The share is obviously a rand-hedge and, although it fell from its high of R343 in February 2020 to lows in January 2021. We advised waiting for a break up through its long-term downward trendline. That break came on 16th September 2019 at R270 per share. It is now trading for R442.49. This share benefits from any weakness in the rand and investors should consider the rand's future prospects before buying.
Our opinion on the current state of RNIReinet (RNI) is an investment holding company whose main asset is a holding of roughly 2,12% of British American Tobacco (BAT) worth about $1,8bn which now accounts for 31% of its net asset value (NAV) - down from 85% ten years ago. This decline from a year ago is because the price of BAT shares has fallen. Most of this reflects the more difficult legal environment for tobacco, especially in the US where the Food and Drug Administration is considering changing the laws on menthol cigarettes. In our view, Reinet shows no great urgency to divest itself of the BAT stake - which continues to contribute good dividends from growth in third world countries, while cigarette sales in first world countries fall. As the price of BAT has fallen, so the other assets in the Reinet portfolio have become more significant. The largest of these is its 46% stake in Pension Insurance Corporation (Penscorp) which now represents 36,8% of its portfolio. Aside from Penscorp, the company also owns a spread of private equity investments which account for around 15% of the portfolio. In its results for the six months to 30th September 2023 the company reported a net asset value (NAV) of 30,89 euros down from the 31,46 euros on 31st March 2023. The company claims a compound growth rate of 8,5% per annum since it listed in March 2009. The share is obviously a rand-hedge and, although it fell from its high of R343 in February 2020 to lows in January 2021. We advised waiting for a break up through its long-term downward trendline. That break came on 16th September 2019 at R270 per share. It is now trading for 42352c. This share benefits from any weakness in the rand and investors should consider the rand's future prospects before buying.
Reinet Investments Head & Shoulders.Reinet Investments seems to have printed a Head & Shoulders Pattern.
The outgoing tide lowers all boats they say.
This is the simple line chart view.
Please do your own analysis. This is not advice.
Smash the Rocket Boost Button if this helped you.
Regards Graham.
Our opinion on the current state of RNIReinet (RNI) is an investment holding company whose main asset is a holding of roughly 2,12% of British American Tobacco (BAT) worth about $1,8bn which now accounts for 31% of its net asset value (NAV) - down from 85% ten years ago. This decline from a year ago is because the price of BAT shares has fallen. Most of this reflects the more difficult legal environment for tobacco, especially in the US where the Food and Drug Administration is considering changing the laws on menthol cigarettes. In our view, Reinet shows no great urgency to divest itself of the BAT stake - which continues to contribute good dividends from growth in third world countries, while cigarette sales in first world countries fall. As the price of BAT has fallen, so the other assets in the Reinet portfolio have become more significant. The largest of these is its 46% stake in Pension Insurance Corporation (Penscorp) which now represents 36,8% of its portfolio. Aside from Penscorp, the company also owns a spread of private equity investments which account for around 15% of the portfolio. In its results for the year to 31st March 2023 the company reported a net asset value of 5,7bn euros (31,46 euros per share) which reflects a growth of 8,8% per annum since March 2009. On 21st July 2023 the company reported that its NAV was 32,98 euros per share. On the 30th September 2023 the company's NAV was 32.79 euros per share. The share is obviously a rand-hedge and, although it fell from its high of R343 in February 2020 to lows in January 2021. We advised waiting for a break up through its long-term downward trendline. That break came on 16th September 2019 at R270 per share. After that, the share moved into long a sideways pattern before breaking up in October 2022. It is now moving strongly upwards and has reached as high as R443 per share in July 2023 before starting to fall again. This share benefits from any weakness in the rand and investors should consider the rand's future prospects before buying.
RNII published this chart on Friday morning, pre-market.
Friday 20-October-2023, 06h30 Reinet Investments (RNI, 38595c). Lowest Level Since April + Head & Shoulder Technical Formation. The share exceeded my previous short/sell target of R398 (reaching a low of R386) which was followed by a rebound and subsequently, another decline which saw the price trade at it's lowest level since April. In the short term, a rebound is possible, however a new primary bearish trend may be developing following the medium to long term overbought conditions which was seen earlier in this year. Head and Shoulder Measured target = R340.
For more research insights, including trade ideas, get in touch today.
Trade 02 (43328) (Long)Capital 100%
Risk on trade - 1%
Expected Return - 15%
Trades are fictional and conducted for portfolio building purposes.
Reasons for trade:
Recessionary Strategy:
- High Interest Rates, provide higher yields for financial sector.
- Weekly Bullish Order flow.
- Daily Intermediate Swing Structure created.
-Hourly ITS finalised.
UPDATE Reinet Rounding Bottom with target on track to R460Reverse Cup and Handle formed broke out and went up.
Now there is a Rounding Bottom (V shape) and the price is showing strong demand still.
7>21>200
RSI>50
Target 1 remains at R460.00
ABOUT THE COMPANY
Reinet Investments S.C.A. is a Luxembourg-based investment vehicle founded in 2008.
The company was created after a restructuring of the Swiss luxury goods company, Richemont.
The purpose of Reinet is to allow investors to directly participate in a diversified portfolio of high-quality assets.
Reinet is listed on the Luxembourg Stock Exchange and its depositary receipts are listed and traded on the Johannesburg Stock Exchange (JSE).
The company's investment strategy is largely focused on long-term capital growth.
Reinet's portfolio spans multiple asset classes and sectors including private equity, listed securities, real estate, and more.
HOW IT GOT ITS NAME
Reinet Investments S.C.A. is named after Reinet, one of the three daughters of Johann Rupert, the company's chairman and a prominent South African entrepreneur. The Rupert family has had a significant influence in the South African business landscape, with stakes in luxury goods, wine and spirits, and other industries. Naming the company "Reinet" serves as a tribute to the Rupert family.
RNI Reinet Investments (RNI, last close 41814c) may be approaching a medium term overbought range.
Here are 3 items to note:
Weekly chart shows price nearing upper boundary of channel (potential) resistance.
A 7-week RSI print above 85 is associated with 'high bullish momentum/approaching overbought' conditions. See lower panel on chart.
Notice that the share is also becoming extended vs it's 50-100 EMA range. Currently +28% above. The only other time that it was higher was in February 2020 it traded +31% above this level.
We could keep this on our watchlist for a mean reversion sell opportunity.
Initial buy idea 20 June 2022 at R273.
Reinet setting itself for great upside to R460Reverse Cup and Handle has formed on the daily chart.
The price broke above the brim level, and since then has made higher lows.
There are other indicators showing upside to come including.
7>21>200
RSI>50
Target 1 = R460.00
CONCERNS:
The price action is very volatile and jumpy. This is not conducive for trending and breakout trading systems as there can be shakeouts and fakeouts. Albeit it being bullish, the risk should remain small 0.5% to 1% for this kind of trade in my books.
ABOUT THE COMPANY
Reinet is primarily an investment holding company that invests in a diversified portfolio of assets, including listed and unlisted companies, private equity, and real estate. The company's investment strategy is focused on creating long-term value through active management and engagement with portfolio companies.
Reinet Investments SE is a Luxembourg-based investment holding company.
It was founded in 2008 as a spin-off from the South African tobacco company, Richemont.
Reinet is a long-term investor in a diversified portfolio of assets, including listed and unlisted companies, private equity, and real estate.
The company has a market capitalization of over R130 billion (as of April 2023).
Johann Rupert, the founder of Richemont, is the Chairman of Reinet Investments.
The company's portfolio includes significant investments in British American Tobacco (BAT), Pension Corporation, and Miura Holdings.
Reinet Investments owns a 2.4% stake in BAT, making it one of the largest shareholders in the tobacco giant.
Reinet also owns a significant stake in the South African telecommunications company, MTN Group.
REINET INVESTMENTS - Yearly Inside BarReinet Investments formed a inside bar for 2021 , range R308.27 - R256.23
Bullish case would be a break of R308.27 to trade towards R348
Early entries and risk management can be done on the smaller Monthly/Weekly/Daily charts
-- MANAGE YOUR RISK - -
Disclaimer: All ideas are my opinion and should not be taken as financial advice.
RNI: heading for its 200-day?Testing some major resistance.
Upside price momentum supports the bullish trend.
A price action above 26500 supports a bullish trend direction.
A recent bullish MACD crossover supports the bullish trend direction.
RSI leaves enough room for further upside price potential.
RNI Range RNI been trading in a range for a while now. From June the big range narrowed to between R275 as support and R295 as resistance. Currently it broken below that support of R275 and traded down to support at R261 area. Keep an eye for a new range between R261 and R275. My preference will be to trade it on the long side only.
RNI: another leg to the downside?Remains below its 200-day simple moving average - which is bearish in nature.
Below 28250 is a bearish trend applicable.
The Linear regression channel also slopes downwards - supporting a bearish trend direction.
Downside price momentum supports the bearish trend.
As some major support.
Potential profit target and stop-loss presented.